Special Situation Investments

Focus on event-driven trades and low risk arbitrage opportunities with short term catalysts

Event-Driven Investment Opportunities

Event-Driven Investment Opportunities, Special Situation Investments

Event-Driven

<ul><li>Future Pak's latest offer for THTX is $3.51/share in cash plus a CVR worth up to $0.99/share.</li><li>THTX's Egrifta SV has gross margins around 90%, while Trogarzo, a licensed drug, has gross margins at 48%.</li><li>Future Pak's offer, including the CVR, values THTX at approximately 4x the gross profits from its commercialized treatments.</li></ul>

Future Pak's latest offer for THTX is $3.51/share in cash plus a CVR worth up to $0.99/share.THTX's Egrifta SV has gross margins around 90%, while Trogarzo, a licensed drug, has gross margins at 48%.Future Pak's offer, including the CVR, values THTX at approximately 4x the gross profits from its commercialized treatments.

セラテクノロジーズは、戦略的見直しとFuture Pakからの複数の買収提案を受け、75%のプレミアムで買収される可能性に直面している。

Theratechnologies

セラテクノロジーズは、戦略的見直しとFuture Pakからの複数の買収提案を受け、75%のプレミアムで買収される可能性に直面している。